Thyroid nodule shape and prediction of malignancy

被引:97
作者
Alexander, EK
Marqusee, E
Orcutt, J
Benson, CB
Frates, MC
Doubilet, PM
Cibas, ES
Atri, A
机构
[1] Brigham & Womens Hosp, Thyroid Unit, Div Endocrinol Diabet & Hypertens, Thyroid Sect,Dept Med, Boston, MA 02115 USA
[2] Brigham & Womens Hosp, Dept Radiol, Boston, MA 02115 USA
[3] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA
[4] Harvard Univ, Sch Med, Boston, MA 02115 USA
[5] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Dept Neurol, Cambridge, MA 02138 USA
[6] Harvard Univ, MIT Hlth Sci & Technol, Beth Israel Deaconess Med Ctr, Cambridge, MA 02138 USA
关键词
D O I
10.1089/thy.2004.14.953
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Thyroid nodules are common; the vast majority benign. Preoperative determination of malignancy remains imprecise, despite fine-needle aspiration (FNA). Numerous risk factors have been proposed for predicting malignancy, though few have been found useful. Oxygen delivery is a crucial component for tumor cell growth. It has been hypothesized that malignant tumors may configure their shape to maximize access to local nutrient delivery. Mathematically, surface area to volume is maximized by a spherical shape. We sought to determine if spherical shape is a predictor of malignancy. Methods: Seven hundred forty-seven consecutive patients underwent ultrasound evaluation and FNA of 993 solid thyroid nodules (< 25% cystic) between 1995 and 2000 and were retrospectively analyzed. Nodules were classified as benign or malignant based on FNA and/or surgical pathology. Spherical shape was estimated by calculating a ratio of the longest to shortest dimensions, and rate of malignancy correlated. Results: Spherical shape was independently correlated with risk of malignancy (p < 0.001). Thyroid cancer was detected in 11% of all nodules, but ranged from 18% in spherical nodules to 5% in those least spherical. Nodules found to have suspicious or intermediate cytology showed similar variation in malignant risk. A long to short axis ratio greater than 2.5 was 100% predictive of a benign process, although present in only 4% of our cohort. A prospective validation was performed and confirmed consistent results (p < 0.01). Conclusion: Spherical shape is associated with an increased rate of malignancy in solid thyroid nodules. Determination of shape may assist in clinical risk assessment of thyroid cancer.
引用
收藏
页码:953 / 958
页数:6
相关论文
共 30 条
[11]   CURRENT EVALUATION OF THYROID-NODULES [J].
GHARIB, H .
TRENDS IN ENDOCRINOLOGY AND METABOLISM, 1994, 5 (09) :365-369
[12]  
GHARIB H, 1996, ENDOCR PRACT, V2, P78
[13]   CONTROVERSIES IN THE MANAGEMENT OF COLD, HOT, AND OCCULT THYROID-NODULES [J].
GIUFFRIDA, D ;
GHARIB, H .
AMERICAN JOURNAL OF MEDICINE, 1995, 99 (06) :642-650
[14]   Role of ultrasound-guided fine-needle aspiration biopsy in evaluation of nonpalpable thyroid nodules [J].
Hagag, P ;
Strauss, S ;
Weiss, M .
THYROID, 1998, 8 (11) :989-995
[15]   Ultrasonography in the evaluation of cold thyroid nodules [J].
Hegedüs, L ;
Karstrup, S .
EUROPEAN JOURNAL OF ENDOCRINOLOGY, 1998, 138 (01) :30-31
[16]   New sonographic criteria for recommending fine-needle aspiration biopsy of nonpalpable solid nodules of the thyroid [J].
Kim, EK ;
Park, CS ;
Chung, WY ;
Oh, KK ;
Kim, DI ;
Lee, JT ;
Yoo, HS .
AMERICAN JOURNAL OF ROENTGENOLOGY, 2002, 178 (03) :687-691
[17]   OUTCOME OF LONG STANDING SOLITARY THYROID-NODULES [J].
KUMA, K ;
MATSUZUKA, F ;
KOBAYASHI, A ;
HIRAI, K ;
MORITA, S ;
MIYAUCHI, A ;
KATAYAMA, S ;
SUGAWARA, M .
WORLD JOURNAL OF SURGERY, 1992, 16 (04) :583-588
[18]   Expression of PAX8-PPARγ1 rearrangements in both follicular thyroid carcinomas and adenomas [J].
Marques, AR ;
Espadinha, C ;
Catarino, AL ;
Moniz, S ;
Pereira, T ;
Sobrinho, LG ;
Leite, V .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2002, 87 (08) :3947-3952
[19]   Usefulness of ultrasonography in the management of nodular thyroid disease [J].
Marqusee, E ;
Benson, CB ;
Frates, MC ;
Doubilet, PM ;
Larsen, PR ;
Cibas, ES ;
Mandel, SJ .
ANNALS OF INTERNAL MEDICINE, 2000, 133 (09) :696-700
[20]   Galectin-3 messenger ribonucleic acid and protein are expressed in benign thyroid tumors [J].
Martins, L ;
Matsuo, SE ;
Ebina, FN ;
Kulcsar, MAV ;
Friguglietti, CUM ;
Kimura, ET .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2002, 87 (10) :4806-4810